FDA limits use of testosterone drugs, warns of possible heart risk

March 3, 2015 10:45 PM

12 0

(Reuters) - The U.S. Food and Drug Administration has asked makers of prescription testosterone therapies to change their labeling to clarify that their products are approved only for men with specific medical conditions and could increase the risk of heart attacks and strokes.

Prescriptions for low testosterone, or "Low T" have soared over the past decade, driven by a surge in use by men facing falling testosterone levels as they age.

Read more

To category page